Somatostatin receptor 2A expression in choroidal neovascularization secondary to age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 8, 2000, Pages 2329-2335

  Lambooij, Antoinette C ^c   Kuijpers, Robert W A M ^d   Van Lichtenauer Kaligis, Elgin G R ^d   Kliffen, Mike ^d   Baarsma, G Seerp ^a   Martin Van Hagen, P ^d   Mooy, Cornelia M ^b  

^a ROTTERDAM EYE HOSPITAL   (Netherlands)

^b Laboratory for Pathology   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OCTREOTIDE; POLYCLONAL ANTIBODY; RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2A; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5; UNCLASSIFIED DRUG;

AGED; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; SUBRETINAL NEOVASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; MACULA LUTEA; MACULAR DEGENERATION; MALE; MIDDLE AGED; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0347853284     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Vingerling JR, Dielemans I, Hofman A, et al. Prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205-210.
2. D'Amore PA. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 1994;35:3974-3979.
3. Kliffen M, Sharma HS, Mooy CM, et al. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol. 1997;81:154-162.
4. Frank RN, Amin RH, Eliott D, et al. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol. 1996; 122:393-403.
5. Kvanta A, Algvere PV, Berglin L, et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1996;37: 1929-1934.
6. Yi X, Ogata N, Komada M, et al. Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol. 1997;235:313-319.
7. Pe'er J, Folberg R, Itin A, et al. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology. 1998;105:412-426.
8. Pe'er J, Shweiki D, Itin A, et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995;72: 638-644.
9. Lopez PF, Sippy BD, Lambert HM, et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1996;37:855-868.
10. Ishibashi T, Hata Y, Yoshikawa H, et al. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol. 1997;235:159-167.
11. Amin R, Puklin JE, Frank RN. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci. 1994;35:3178-3188.
12. Kitaoka T, Morse LS, Schneeberger S, et al. Expression of FGF5 in choroidal neovascular membranes associated with ARMD. Curr Eye Res. 1997;16:396-399.
13. Reddy VM, Zamora RL, Kaplan HJ. Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1995;120:291-301.
14. Smith LEH, Kopchick JJ, Chen W, et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science. 1997;276:1706-1709.
15. Johnson J, Wong H, Walsh JH, Brecha NC. Expression of the somatostatin subtype 2A receptor in the rabbit retina. J Comp Neurol. 1998;393:93-101.
16. Helboe L, Moller M. Immunohistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina. Invest Ophthalmol Vis Sci. 1999;40:2376-2382.
17. Mori M, Aihara M, Shimizu T. Differential expression of somatostatin receptors in the rat eye: sstR4 is intensely expressed in the iris/ciliary body. Neurosci Lett. 1997;223:185-188.
18. van der Schaft TL, de Bruijn WC, Mooy CM, et al. Histologic features of the early stages of age-related macular degeneration: a statistical analysis. Ophthalmology. 1992;99:278-286.
19. Grossniklaus HE, Gass JDM. Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol. 1998;126:59-69.
20. Grossniklaus HE, Green R. Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular Surgery Trials Research Group. Arch Ophthalmol. 1998;116: 745-749.
21. Gu Y-Z, Schonbrunn A. Coupling specificity between somatostatin receptor sst2A and G proteins: isolation of the receptor-G protein complex with a receptor antibody. Mol Endocrinol. 1997;11:527-537.
22. Holland LJ, Liu Q, Van Koetsveld PM, et al. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors. J Clin Endocrinol Metab. 1999;84:775-780.
23. Ferone D, van Hagen PM, van Koetsveld PM, et al. In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells. Endocrinology. 1999;140:373-380.
24. Sagar SM, Marshall PE, Onesti ST, et al. Somatostatin immunoreactivity in the rabbit retina. Invest Ophthalmol Vis Sci. 1986;27:316-322.
25. Zalutsky RA, Miller RF. The physiology of somatostatin in the rabbit retina. J Neurosci 1990;10:383-393.
26. Grant MB, Caballero S, Millard WJ. Inhibition of IGF-I and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue, octreotide: a potential treatment for ocular neovascularization. Regul Pept. 1993;48:267-278.
27. Mallet B, Vialettes B, Haroche S, et al. Stabilization of severe proliferative diabetic retinopathy by long-term treatment with SMS 201-995. Diabetes Metab. 1992;18:438-444.
28. Shumack SL, Grossman LD, Chew E, et al. Growth hormone suppression and nonproliferative diabetic retinopathy: a preliminary feasibility study. Clin Invest Med. 1990;5:287-292.
29. Kirkegaard C, Norgaard K, Snorgaard O, et al. Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in type 1 (insulin-dependent) diabetes mellitus. Acta Endocrinol (Copenh). 1990;122:766-772.
30. Reubi JC, Laissue JA, Waser B, et al. Immunohistochemical detection of somatostatin sst2A receptors in the lymphatic, smooth muscular, and peripheral nervous systems of the human gastrointestinal tract: facts and artifacts. J Clin Endocrinol Metab. 1999; 84:2942-2950.
31. Ten Bokum AMC, Hofland LJ, de Jong G, et al. Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas. Eur J Clin Invest. 1999;29:630-636.
32. Kvanta A. Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts. Curr Eye Res. 1995;14: 1015-1020.
33. Sunderkotter C, Goebeler M, Schulze-Osthoff K, et al. Macrophage-derived angiogenesis factors. Rev Pharmacol Ther. 1991; 51:195-216.
34. Chao TC, Cheng HP, Walter RJ. Somatostatin and macrophage function: modulation of hydrogen peroxide, nitric oxide and tumor necrosis factor release. Regul Pept. 1995;58:1-10.
35. Peluso G, Petillo O, Melone MA, et al. Modulation of cytokine production in activated human monocytes by somatostatin. Neuropeptides. 1996;30:443-451.
36. Komorowski J, Stepien H. Somatostatin stimulates the release of interleukin-6 from human peripheral blood monocytes in vitro. Neuropeptides. 1995;29:77-81.
37. Ten Bokum AMC, Lichtenauer-Kaligis EGR, Melief MJ, et al. Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritis. J Endocrinol. 1999;161:167-175.
38. Ferriero DM, Head VA, Edwards RH, Sagar SM. Somatostatin mRNA and molecular forms during development of the rat retina. Brain Res Dev Brain Res. 1990;57:15-19.
39. Larsen JN, Bersani M, Olcese J, Holst JJ, Moller M. Somatostatin and prosomatostatin in the retina of the rat: an immunohistochemical, in-situ hybridization, and Chromatographic study. Vis Neurosci. 1990;5:441-452.
40. Yamaguchi K, Gaur VP, Spira AW, Turner JE. Cellular localization of Somatostatin mRNA in rat retina. Neuropeptides. 1990;17:13-16.
41. Wulfsen I, Meyerhof W, Fehr S, Richter D. Expression pattern of rat Somatostatin receptor genes in pre-and postnatal brain and pituitary. J Neurochem. 1993;61:1549-1552.
42. Kuhota A, Yamada Y, Kagimoto S, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest. 1994;93:1321-1325.